513 assets in Ovarian Cancer

Belzutifan

Bevacizumab-Awwb

Cab-Ror2-Adc (Ba-3021)

CD47/SIRPA-BLOCKING AGENT ALX148

Disitamab

Efbemalenograstim Alfa

Etodolac

Fapi-46

FAPI74

Fludeoxyglucose

Fuzuloparib

Giredestrant

hcw9218

hlx43

Hydroxychloroquine

Immunoglobulin G1 (De-450-Lysine), Anti-(Human Tyrosine Kinase Receptor Axl) (Human-Mus Musculus Monoclonal Ba301 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal Ba301 .Kappa.-Chain, Dimer, Thioether With N-(((4-((N-(6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl)-L-Valy L-N5-(Aminocarbonyl)-L-Ornithyl)Amino)Phenyl)Methoxy)Carbonyl)-N-Methyl-L-Valyl-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-Hydroxy-1-Methyl-2-Phenylethyl)Amino)-1-Methoxy-2-Methyl-3-Oxopropyl)-1-Pyrrolidinyl)-2-Methoxy-1-((1S)-1-Methylpropyl)-4-Oxobutyl)-N-Methyl-L-Valinamide

Inavolisib

Interferon-Alfa-2A

Lartesertib

ly3023414

Minoxidil

N-(5-ISOQUINOLINESULFONYL)-1,4-PERHYDRODIAZEPINE

Nesuparib

PF-0704091

qlc1101

Retlirafusp Alfa

Riluzole

Romiplostim

Sctil

Sleeping Beauty Transposed Pbl

Tart Cherry

Tcr Transduced T-Cells

Tegtociclib

Telmisartan

Tretinoin

Tuvusertib

Utidelone

Utomilumab

uv1

Valemetostat

Volrustomig

Yangzheng Xiaoji

Zanidatamab

αdc1 vaccine

Ashwagandha

Nelfinavir

Ntx-301

Rintatolimod

Son-1010

Theo-260